Alexander Zürcher
Vermogen: 90 706 $ op 31-05-2026
Vermogen: 90 706 $ op 31-05-2026
Mr. Alexander Zürcher is a Chief Operating Officer at Molecular Partners AG.
Mr. Zürcher was previously employed as a Director-Drug Product Development by Cytos Biotechnology AG and a Head-Research & Development Operations by Spirig Pharma AG.
He received his graduate degree from the University of Basel.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2025 | 22.571 ( 0,06% ) | 90 706 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MOLECULAR PARTNERS AG | Operationeel Directeur | 01-07-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
Spirig Pharma AG
Spirig Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | - |
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Commercial Services |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
Spirig Pharma AG
Spirig Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau